Which companies overlap with German High-Grade Non-Hodgkin's Lymphoma Study Group's portfolio?

Top competitors by shared drug class: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/german-high-grade-non-hodgkin-s-lymphoma-study-group.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

German High-Grade Non-Hodgkin's Lymphoma Study Group — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

German High-Grade Non-Hodgkin's Lymphoma Study Group pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
R-CHOEP 14 with 12x Rituximab	R-CHOEP 14 with 12x Rituximab	phase 3	Chemotherapy combination with monoclonal antibody	CD20 (rituximab component); DNA/topoisomerase II (chemotherapy components)	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for German High-Grade Non-Hodgkin's Lymphoma Study Group:

Cite this brief

Drug Landscape (2026). German High-Grade Non-Hodgkin's Lymphoma Study Group — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/german-high-grade-non-hodgkin-s-lymphoma-study-group. Accessed 2026-05-17.